DK0820507T3 - NDF-peptider - Google Patents

NDF-peptider

Info

Publication number
DK0820507T3
DK0820507T3 DK96910630T DK96910630T DK0820507T3 DK 0820507 T3 DK0820507 T3 DK 0820507T3 DK 96910630 T DK96910630 T DK 96910630T DK 96910630 T DK96910630 T DK 96910630T DK 0820507 T3 DK0820507 T3 DK 0820507T3
Authority
DK
Denmark
Prior art keywords
ndf
peptides
heregulins
egf
stimulate
Prior art date
Application number
DK96910630T
Other languages
English (en)
Inventor
Josette Francoise Cranahan
Shinichi Hara
Hsieng Sen Lu
John Philip Mayer
Stevel Kiyoshi Yoshinaga
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DK0820507T3 publication Critical patent/DK0820507T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK96910630T 1995-04-06 1996-03-27 NDF-peptider DK0820507T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/417,640 US5670342A (en) 1995-04-06 1995-04-06 NDF peptides

Publications (1)

Publication Number Publication Date
DK0820507T3 true DK0820507T3 (da) 2004-10-04

Family

ID=23654814

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96910630T DK0820507T3 (da) 1995-04-06 1996-03-27 NDF-peptider

Country Status (11)

Country Link
US (4) US5670342A (da)
EP (1) EP0820507B8 (da)
JP (1) JPH11503321A (da)
AT (1) ATE274054T1 (da)
AU (1) AU5377196A (da)
CA (1) CA2216165C (da)
DE (1) DE69633172T2 (da)
DK (1) DK0820507T3 (da)
ES (1) ES2224162T3 (da)
PT (1) PT820507E (da)
WO (1) WO1996031599A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136558A (en) * 1997-02-10 2000-10-24 Genentech, Inc. Heregulin variants
US6387638B1 (en) * 1997-02-10 2002-05-14 Genentech, Inc. Heregulin variants
US20010023241A1 (en) * 1998-02-04 2001-09-20 Sliwkowski Mark X. Use of heregulin as a growth factor
US6080845A (en) * 1998-08-05 2000-06-27 Amgen Inc. Monoclonal antibody against utricular epithelium
US6017886A (en) * 1998-08-05 2000-01-25 Amgen Inc. Use of NDF peptide as growth factor for sensory epithelium
CA2345899A1 (en) * 1998-11-07 2000-05-18 Genentech, Inc. Method for enhancing proliferation of inner ear hair cells using ligands for her2 and/or her3 receptors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530109A (en) * 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
WO1994028133A1 (en) * 1993-05-21 1994-12-08 Amgen Inc. Recombinant neu differentiation factors

Also Published As

Publication number Publication date
US5849705A (en) 1998-12-15
US5929032A (en) 1999-07-27
CA2216165C (en) 2000-08-08
PT820507E (pt) 2004-11-30
EP0820507B8 (en) 2005-01-05
JPH11503321A (ja) 1999-03-26
DE69633172T2 (de) 2005-08-11
ATE274054T1 (de) 2004-09-15
CA2216165A1 (en) 1996-10-10
WO1996031599A1 (en) 1996-10-10
EP0820507A1 (en) 1998-01-28
EP0820507B1 (en) 2004-08-18
ES2224162T3 (es) 2005-03-01
US5670342A (en) 1997-09-23
DE69633172D1 (en) 2004-09-23
US5686415A (en) 1997-11-11
AU5377196A (en) 1996-10-23

Similar Documents

Publication Publication Date Title
DE69435096D1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
ES2082003T3 (es) Deshidrodidemnina b.
FI961621A0 (fi) Proteiini:farnesyylitranseraasin substituoidut tetra- ja pentapeptidi-inhibiittorit
DE69631141D1 (de) Biologisch aktive peptide und ihre zubereitungen und verwendungen
DE69620877T2 (de) Arzneimittelformulierungen für il-12
UA43348C2 (uk) Водна фармацевтична композиція, що включає фактор росту нерва (варіанти) та ліофілізований фармацевтичний склад
DE69637669D1 (de) Myogene differenzierung menschlicher mesenchymaler stammzellen
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
DE69733715D1 (de) Antiparasitäre mittel
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
PT862452E (pt) Formulacao de estabilizacao para o ngf
DK0820507T3 (da) NDF-peptider
MX9803662A (es) Oligopeptidos novedosos, preparacion y uso de estos.
NZ311175A (en) Gene preparation comprising a gene incorporated into a biocompatible carrier which preferably contains collagen
FI960839A (fi) Uusia tripeptidejä, jotka ovat käyttökelpoisia immuuni- ja CNS-terapiassa
AU2766597A (en) Biologically active protein (collagen fragment hf-coll-18/514cf) for inhibiting the growth of tumours and capillary profilerations
ES2160969T3 (es) Derivados anticonvulsivos utiles en el tratamiento de la psoriasis.
ATE223427T1 (de) Modifizierte kojibioside analoge
AU3557697A (en) Variants of human ciliary neurotrophic factor (hcntf) with a range of action different from that of the wild-type molecule
IT1251961B (it) Peptidi che rappresentano permutazioni della sequenza del mastoparano
FR2741350B1 (fr) Peptides derives de la proteine oncogene bcr-abl exprimes par des cellules leucemiques et leur utilisation pour la therapie des leucemies humaines
AU3564595A (en) Biologically active molecules derived from neurotrophins
UA43383C2 (uk) Штам синьо-зелених водоростей spirulina platensis - продуцент біологічно активних речовин з антибластомними та антимікробними властивостями
ECSP961747A (es) Producto del gen de la obesidad
MX9703208A (es) Tetra-y pentapeptidos substituidos inhibidores de proteina; farnesil transferasa.